比较双频指数监测与临床评估指导ICU深度镇静:对谵妄减少及镇静药物剂量的影响——一项随机试验
这项随机对照试验在三级混合ICU纳入需要深度镇静超过8小时的患者99例,随机分为临床评估组与BIS组(BIS范围40-60),两组均使用BIS传感器但临床评估组屏幕遮盖。主要终点14天内无谵妄无昏迷天数两组无显著差异(P=.1);BIS组丙泊酚剂量显著低于临床评估组(1.44 vs 1.77 mg/kg/h,P=.03)。深度镇静期间临床评估组BIS值<40的时间占比46%,BIS组32%(P=.03)。亚组分析中镇静超过24小时的患者BIS组无谵妄无昏迷天数增加(中位数8天 vs 1天,P=.04)。
要点
- BIS指导深度镇静(目标BIS 40-60)未显著改善14天内无谵妄无昏迷天数(P=.1)。
- BIS组丙泊酚剂量显著低于临床评估组:1.44 mg/kg/h(95%CI 1.04-1.83)vs 1.77 mg/kg/h(95%CI 1.60-1.93),P=.03。
- 深度镇静期间BIS值<40的时间占比:临床评估组46%(95%CI 35%-57%)vs BIS组32%(95%CI 25%-40%),P=.03。
- 镇静超过24小时的患者亚组中,BIS组无谵妄无昏迷天数中位数8天(IQR 0-13)vs 临床评估组1天(IQR 0-9),P=.04。
适用人群与场景
- 三级混合ICU中需要深度镇静超过8小时的患者。
诊断标准与关键阈值
- 深度镇静定义为Richmond躁动镇静评分(RASS)-4或-5分。
- BIS组目标BIS范围为40-60。
处置流程与药物剂量
- 两组均使用BIS传感器,临床评估组屏幕保持遮盖。
- 深度镇静结束后移除BIS传感器,由对随机分组设盲的研究者每日两次评估谵妄。
研究设计与关键结果
- 随机对照试验,纳入99例患者,比较临床评估与BIS指导深度镇静。
- 主要终点14天内无谵妄无昏迷天数两组无显著差异(P=.1)。
- 丙泊酚剂量BIS组显著低于临床评估组:1.44 mg/kg/h(95%CI 1.04-1.83)vs 1.77 mg/kg/h(95%CI 1.60-1.93),P=.03。
- 深度镇静期间BIS值<40的时间占比:临床评估组46%(95%CI 35%-57%)vs BIS组32%(95%CI 25%-40%),P=.03。
- 亚组分析中镇静超过24小时的患者,BIS组无谵妄无昏迷天数中位数8天(IQR 0-13)vs 临床评估组1天(IQR 0-9),P=.04。
证据类型、等级与局限
- 证据类型:随机对照试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- BIS指导深度镇静未改善总体无谵妄无昏迷天数,但可减少丙泊酚用量。
- 对于需要镇静超过24小时的患者,BIS指导可能增加无谵妄无昏迷天数(作者结论)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Sedative overdoses pose a risk of delirium among patients in the ICU, with potential mitigation through the use of a processed EEG monitor (the bispectral index [BIS]) to guide depth of sedation.
RESEARCH QUESTION: Can BIS-guided deep sedation (Richmond Agitation Sedation Scale [RASS] score, -4 or -5) reduce sedative dosage and increase delirium-free and coma-free (DFCF) days?
STUDY DESIGN AND METHODS: A randomized controlled trial was conducted in a tertiary mixed ICU, enrolling patients requiring deep sedation for > 8 h. Patients were assigned randomly to either the clinical assessment (CA) or BIS groups (BIS range, 40-60). Both groups used a BIS sensor, whereas the CA group's screen remained covered. After deep sedation, BIS sensors were removed, and delirium was assessed twice daily by researchers masked to the randomization. The primary outcome was the number of DFCF days within 14 days after deep sedation. Additionally, we compared doses of sedative drugs and BIS values during deep sedation.
RESULTS: Ninety-nine patients were included in the study. We found no significant difference in DFCF days (P = .1) between CA and BIS arms, but propofol doses were significantly lower in the BIS group (CA group, 1.77 mg/kg/h [95% CI, 1.60-1.93] vs BIS group, 1.44 mg/kg/h [95% CI, 1.04-1.83]; P = .03). During deep sedation, the CA group spent 46% of the total hours (95% CI, 35%-57%) with BIS values of < 40, whereas the BIS group spent 32% (95% CI, 25%-40%; P = .03). Subgroup analysis focusing on patients sedated for > 24 h revealed an increase in DFCF days in the BIS group (CA group: median, 1 day [interquartile range, 0-9 days] vs BIS group: median, 8 days [interquartile range, 0-13 days]; P = .04).
INTERPRETATION: In this study, BIS-guided deep sedation did not improve DFCF days, but did reduce sedative drug use. In patients requiring sedation for > 24 h, it showed an improvement in DFCF days.
TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT03840577; URL: www.
CLINICALTRIALS: gov.
参考来源
- Huespe I, Giunta D, Acosta K, et al. Comparing Bispectral Index Monitoring vs Clinical Assessment for Deep Sedation in the ICU: Effects on Delirium Reduction and Sedative Drug Doses-A Randomized Trial. Chest. 2024. PMID: 38901489. doi:10.1016/j.chest.2024.05.031
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。